Harrow Health to Participate in H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

Rhea-AI Summary

Harrow Health, Inc. (Nasdaq: HROW), a pharmaceutical company specializing in eyecare, announced participation in the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on August 17, 2022. CEO Mark L. Baum and CFO Andrew Boll will represent the company. A pre-recorded presentation will be available on Harrow's investor relations webpage starting at 7:00 a.m. ET on that date and archived for 90 days. Additionally, management will engage in one-on-one meetings during the conference, which interested investors can request through H.C. Wainwright.

NASHVILLE, Tenn.--(BUSINESS WIRE)-- Harrow Health, Inc. (Nasdaq: HROW), an eyecare pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medicines, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the H.C. Wainwright 2^nd Annual Ophthalmology Virtual Conference to be held on August 17, 2022.

Harrow Health’s pre-recorded presentation will be available via a link on the investor relations section of its website, harrowinc.com, beginning at 7:00 a.m. ET on Wednesday, August 17, 2022, and will remain archived there for approximately 90 days. Harrow Health’s management team will be participating in one-on-one meetings during the conference. Interested investors can request meetings exclusively via H. C. Wainwright.

About Harrow Health

Harrow Health, Inc. (Nasdaq: HROW) is an eyecare pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable. For more information about Harrow Health, please visit the Investors section of the corporate website, harrowinc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220811005152/en/

Jamie Webb

Director of Communications and Investor Relations

jwebb@harrowinc.com

615-733-4737

Source: Harrow Health, Inc.

FAQ

What is the date of the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference involving HROW?

The conference will take place on August 17, 2022.

Who from Harrow Health will participate in the ophthalmology conference?

CEO Mark L. Baum and CFO Andrew Boll will represent Harrow Health.

Where can I find Harrow Health's presentation for the conference?

The pre-recorded presentation will be available on Harrow's investor relations website starting at 7:00 a.m. ET on August 17, 2022.

How long will Harrow Health's conference presentation be available online?

The presentation will remain archived for approximately 90 days.

How can investors request one-on-one meetings during the ophthalmology conference?

Investors can request meetings exclusively through H.C. Wainwright.